GMO Emerging Country Debt UCITS Fund, a sub-fund of GMO Investments ICAV updates its Form D — $87.5M sold
Sold rose to $NaN (+$720K, +1 investor) in 401 days since the previous filing.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-11-05 | D/A | $86.8M | 3 | |
| 2025-12-11 | D/A | $87.5M | 4 | +$720K |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Gmo Emerging Country vehicles →
Sold rose to $NaN (+$720K, +1 investor) in 401 days since the previous filing.
Sold rose to $NaN (+$3M) in 401 days since the previous filing.
| ARRON DAY | Director |
| JOHN FITZPATRICK | Director |
| EIMEAR COWHEY | Director |
| DAVID BOHAN | Director |
[email protected] · observed Work emails for the people on the filing, labelled by confidence — subscribers
Signed by ARRON DAY, DIRECTOR.
Relevant to: Fund audit & tax, Fund administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans.